Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > One Weight Loss Strategy Is 5x More Effective Than Ozempic, Trials Show : ScienceAlert
Tech and Science

One Weight Loss Strategy Is 5x More Effective Than Ozempic, Trials Show : ScienceAlert

Last updated: June 20, 2025 12:25 am
Share
One Weight Loss Strategy Is 5x More Effective Than Ozempic, Trials Show : ScienceAlert
SHARE

Ozempic and Semaglutide Medications vs. Bariatric Surgery: Which is More Effective for Weight Loss?

Ozempic and other semaglutide medications have gained popularity for their ability to help people shed pounds. However, a recent study conducted by researchers at New York University (NYU) has revealed that these medications are still not as effective as bariatric surgery when it comes to weight loss.

The study compared sleeve gastrectomy and gastric bypass operations with semaglutide or tirzepatide, which are glucagon-like peptide-1 (GLP-1) receptor agonists. These drugs mimic the natural GLP-1 hormone, which controls appetite.

Using health records, the researchers matched individuals who had taken weight loss drugs with those who had undergone bariatric surgery, based on age, body mass index, and blood sugar levels.

Ozempic Isn't Actually The Most Effective Option For Weight Loss, Scientists Confirm
(aprott/iStock/Getty Images Plus)

The findings revealed that individuals in the surgery group lost an average of 25.7 percent of their total body weight over two years, while those in the medication group only lost 5.3 percent.

One reason for this difference is that some patients do not adhere to their GLP-1 medications, whereas surgery provides more permanent results. Additionally, the researchers observed consistently better results with surgery over shorter time frames.

Avery Brown, a surgical resident at NYU Langone Health, noted, “Clinical trials show weight loss between 15 percent to 21 percent for GLP-1s, but this study suggests that weight loss in the real world is considerably lower even for patients who have active prescriptions for an entire year.”

Despite the study being funded by the American Society for Metabolic and Bariatric Surgery (ASMBS), which promotes surgical options, the researchers emphasize that semaglutide treatments still show positive results. With the increasing popularity of GLP-1 prescriptions, it is essential to compare them to established surgical methods to determine the most suitable option for each individual.

See also  Kalshi closes $185M round as rival Polymarket reportedly seeks $200M

While GLP-1 drugs are more commonly prescribed than surgery, many individuals do not adhere to taking them regularly. On the other hand, only a small percentage of eligible individuals opt for surgery as a weight loss solution.

It is important to note that Ozempic, in addition to aiding in weight loss, was initially approved for treating type 2 diabetes due to its ability to lower blood sugar levels. Studies have also shown its potential to reduce the risk of cancer and cardiovascular disease.

Bariatric surgery was associated with improved blood sugar control in the study, highlighting additional benefits of surgical intervention.

However, surgery is not without its drawbacks. While safe, the procedures are invasive, permanent, and require patients to adhere to strict diet and exercise regimens.

Karan Chhabra, a bariatric surgeon at the NYU Grossman School of Medicine, stated, “In future studies, we will aim to identify what healthcare providers can do to optimize GLP-1 outcomes, determine which patients are better suited for bariatric surgery versus GLP-1s, and assess the impact of out-of-pocket costs on treatment success.”

The research findings were presented at the ASMBS annual meeting in 2025.

TAGGED:EffectiveLossOzempicScienceAlertShowStrategytrialsWeight
Share This Article
Twitter Email Copy Link Print
Previous Article MM6 Maison Margiela Resort 2026 Collection MM6 Maison Margiela Resort 2026 Collection
Next Article Europe and Iran set for first high-level talks since start of conflict Europe and Iran set for first high-level talks since start of conflict
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

An Astronaut Finds Symbiosis with Nature in Agus Putu Suyadnya’s Uncanny Paintings — Colossal

Agus Putu Suyadnya's exhibition "Symbiotic Utopia" offers a glimpse into a future where tropical ecosystems…

June 6, 2025

London’s Heathrow airport closed all day after nearby fire cuts power

London’s Heathrow airport faced a major disruption after a nearby fire caused a significant power…

March 20, 2025

Carl Radke Reveals Soft Bar Opening Date After Summer House Party

Carl Radke, known for his appearance on the reality show Summer House, is excited for…

July 30, 2025

Disney Japan Taps Tamotsu Hiiro as New Managing Director

The Walt Disney Company has announced a new leader at the helm of its operations…

March 28, 2025

Trump signs executive order designating Antifa a ‘domestic terrorist organization’

On Monday, President Trump enacted an executive order that classifies the enigmatic left-wing organization Antifa…

September 23, 2025

You Might Also Like

The Interplanetary Race to Study Interstellar Comet 3I/ATLAS
Tech and Science

The Interplanetary Race to Study Interstellar Comet 3I/ATLAS

October 31, 2025
SOC teams face 51-second breach reality—Manual response times are officially dead
Tech and Science

SOC teams face 51-second breach reality—Manual response times are officially dead

October 31, 2025
The New Scientist Book Club’s verdict on Our Brains, Our Selves: A mix of praise and misgivings
Tech and Science

The New Scientist Book Club’s verdict on Our Brains, Our Selves: A mix of praise and misgivings

October 31, 2025
Tech Advisor December 2025 Digital Magazine
Tech and Science

Tech Advisor December 2025 Digital Magazine

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?